HAEMONETICS CORP Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Haemonetics Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
  • Haemonetics Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 28, 2024 was 51.2M shares, a 0.3% decline year-over-year.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51.4M shares, a 0.05% decline from 2022.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 51.4M shares, a 0.13% increase from 2021.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 51.4M shares, a 0.12% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 51.2M -156K -0.3% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 51.6M +224K +0.44% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 51.4M -23K -0.05% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 51.4M +226K +0.44% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 51.4M -162K -0.31% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 51.3M -343K -0.66% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 51.4M +67K +0.13% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 51.2M -125K -0.24% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 51.6M +100K +0.19% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 51.7M +744K +1.46% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 51.4M +61K +0.12% Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 51.3M -19K -0.04% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 51.5M +365K +0.71% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 50.9M -308K -0.6% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 51.3M -523K -1.01% Dec 27, 2020 Apr 3, 2021 10-K 2023-05-22
Q4 2020 51.4M -275K -0.53% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 51.1M -953K -1.83% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 51.2M +237K +0.47% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 51.8M -1.13M -2.13% Dec 29, 2019 Mar 28, 2020 10-K 2022-05-25
Q4 2019 51.6M -1.18M -2.24% Sep 29, 2019 Dec 28, 2019 10-Q 2021-02-02
Q3 2019 52M -1.09M -2.06% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-04
Q2 2019 51M -1.11M -2.13% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 52.9M -559K -1.05% Dec 30, 2018 Mar 30, 2019 10-K 2021-05-26
Q4 2018 52.8M -268K -0.51% Sep 30, 2018 Dec 29, 2018 10-Q 2020-02-04
Q3 2018 53.1M +157K +0.3% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-01
Q2 2018 52.1M -692K -1.31% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 53.5M +1.98M +3.84% Dec 31, 2017 Mar 31, 2018 10-K 2020-05-20
Q4 2017 53.1M +987K +1.89% Oct 1, 2017 Dec 30, 2017 10-Q 2019-02-05
Q3 2017 53M +1.28M +2.48% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 52.8M +1.79M +3.51% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-07
Q1 2017 51.5M +614K +1.21% Jan 1, 2017 Apr 1, 2017 10-K 2019-05-22
Q4 2016 52.1M +1.36M +2.68% Oct 2, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 51.7M +514K +1% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-07
Q2 2016 51M -339K -0.66% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-07
Q1 2016 50.9M -1.18M -2.26% Dec 27, 2015 Apr 2, 2016 10-K 2018-05-23
Q4 2015 50.7M -1.22M -2.35% Sep 27, 2015 Dec 26, 2015 10-Q 2017-02-06
Q3 2015 51.2M -738K -1.42% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-07
Q2 2015 51.4M -381K -0.74% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-01
Q1 2015 52.1M -288K -0.55% Dec 28, 2014 Mar 28, 2015 10-K 2017-05-24
Q4 2014 52M -549K -1.05% Sep 28, 2014 Dec 27, 2014 10-Q 2016-02-02
Q3 2014 51.9M -436K -0.83% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 51.7M +510K +1% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 52.4M +118K +0.23% Dec 29, 2013 Mar 29, 2014 10-K 2016-06-01
Q4 2013 52.5M -95K -0.18% Sep 29, 2013 Dec 28, 2013 10-Q 2015-02-05
Q3 2013 52.4M +47K +0.09% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-04
Q2 2013 51.2M -633K -1.22% Mar 31, 2013 Jun 29, 2013 10-Q 2014-07-31
Q1 2013 52.3M +669K +1.3% Dec 30, 2012 Mar 30, 2013 10-K 2015-05-22
Q4 2012 52.6M +1.73M +3.4% Sep 30, 2012 Dec 29, 2012 10-Q 2014-01-30
Q3 2012 52.3M +26.5M +102% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 51.9M +25.6M +97.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 51.6M +398K +0.78% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-22
Q4 2011 50.9M +25.4M +99.4% Oct 2, 2011 Dec 31, 2011 10-Q 2013-02-01
Q3 2011 25.8M +615K +2.44% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 26.2M +513K +2% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 51.2M Jan 2, 2011 Apr 2, 2011 10-K 2013-05-20
Q4 2010 25.5M Oct 3, 2010 Jan 1, 2011 10-Q 2012-02-06
Q3 2010 25.2M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-03
Q2 2010 25.7M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.